Login to Your Account

Financings Roundup

Derma Sciences Enters Home Stretch with $29.3M Funding

By Catherine Shaffer
Staff Writer

Friday, December 7, 2012
Derma Sciences Inc. priced an underwritten public offering of 3.062 million shares of common stock at $10.34 per share, for net proceeds of about $29.3 million to support continued development of its candidate for diabetic foot ulcers, DSC127.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription